ESC Premium Access

Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options

Event: ESC Congress 2018
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Sponsored by Cleveland Clinic
Date: 26 August 2018
Time: 13:00 - 14:00

Congress Session

4 presentations in this session

Basic science and mechanism of action of lipoprotein(a).

Speaker: Professor S. Tsimikas (San Diego, US)
Thumbnail

Epidemiology and clinical trial data of lipoprotein(a).

Speaker: Doctor L. Cho (Cleveland, US)
Thumbnail

Current and future treatment strategies to lower lipoprotein(a) .

Speaker: Professor S. Nissen (Cleveland, US)
Thumbnail

Panel discussion and Q&A.

Thumbnail

3 speakers from this session

Professor Sotirios Tsimikas

University of California San Diego, San Diego (United States of America)
6 presentations
0 follower

Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)
14 presentations
0 follower

Professor Steven E Nissen

Cleveland Clinic Foundation, Cleveland (United States of America)
11 presentations
0 follower

This platform is supported by

logo Novo Nordisk